Skip to content

VALUE study

VAginal NOTES versus Laparoscopic hysterectomy in Uterine Endometrioid Cancer (VALUE-study): a multicentre randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24941
Enrollment
147
Registered
2021-04-07
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low grade endometrial cancer

Interventions

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - 18 years and older - Written and orally given informed consent - Patients with a histologically confirmed low grade endometrial carcinoma with no signs of progressive or metastatic disease - Patients with atypical hyperplasia - Clinical assessment of feasibility to perform laparoscopic or vNOTES hysterectomy with BSO

Exclusion criteria

Exclusion criteria: Patients with high grade endometrial cancer Patients with advanced stage low grade endometrial cancer Patients unfit for surgery Significant language barrier Contraindication for laparoscopic or vNOTES hysterectomy such as: • History of rectal surgery • History of pelvic radiation • History of pelvic inflammatory disease, especially prior tubo-ovarian or pouch of Douglas abscess • 2 or more caesarean sections in history

Design outcomes

Primary

MeasureTime frame
percentage of patients treated in day-care setting

Secondary

MeasureTime frame
Major complications, severity scored by Clavien-Dindo classification o injuries to bowel, bladder, ureter, vessels, nerves o thrombo-embolic events o haematoma requiring surgical intervention o haemorrhage requiring transfusion or surgical intervention o wound dehiscence requiring surgical intervention o wound infections including vaginal vault abscesses requiring surgical intervention or admission Minor complications o urinary tract infections in the first 2 weeks postoperative for which antibiotics are started o surgical site infections; excluding vaginal vault abscesses that do not require surgical intervention but are treated expectantly or with antibiotics. Treatment related outcomes o conversion rate (number of vNOTES cases that were converted to TLH) o operating time (measured from the start of the inscision until end of surgery) o time in operation room (measured from the entry and departure of the patients in the OR) o successful resection of adnexa o total amount of CO2 used during procedure. (measured in litres CO2) o blood loss (measured in millilitres) o hospital stay (measured in hours) o usage of analgesics (usage and amount of paracetamol, NSAIDs or opioids) o resumption of daily activity (scored by return to daily activity questionnaire) o hospital readmission within 6 weeks after surgery o post-operative pain the first 48 hours after surgery (measured on a numeric rating scale) Quality of life up to 12 weeks o QoR-40 questionnaire (day 1,2 and 7) o Recovery-Index 10 (week 1,4,6, 12)

Contacts

Public ContactAlbert Tjalsma

Albert Schweitzer Ziekenhuis

a.s.tjalsma@asz.nl0786551923

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)